Valuation: Carlsmed, Inc.

Market Cap 408M 366M 336M 305M 570M 38.76B 580M 4.01B 1.61B 20.39B 1.53B 1.5B 64.29B P/E 2026 *
-10x
P/E 2027 * -10.2x
Enterprise Value 408M 366M 336M 305M 570M 38.76B 580M 4.01B 1.61B 20.39B 1.53B 1.5B 64.29B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 3.78x
Free-Float
54.88%
Yield 2026 *
-
Yield 2027 * -
1 day-5.20%
1 week+2.89%
1 month+6.25%
3 months+18.75%
6 months+68.17%
Current year+21.05%
1 week 14.51
Extreme 14.5101
16.31
1 month 13.31
Extreme 13.31
16.31
Current year 8.5
Extreme 8.5
17.23
1 year 8.5
Extreme 8.5
17.23
3 years 8.5
Extreme 8.5
17.23
5 years 8.5
Extreme 8.5
17.23
10 years 8.5
Extreme 8.5
17.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 50 03/06/2018
Chief Executive Officer 50 03/06/2018
Director of Finance/CFO 55 27/09/2026
Director TitleAgeSince
Chairman 50 03/06/2018
Director/Board Member 50 03/06/2018
Director/Board Member 66 15/12/2020
Date Insider Type Main position Quantity % Market Cap. Importance
05/10/26 Exercice

Chief Operating Officer

2,241 0.0084%
30/09/26 Exercice

Chief Operating Officer

729 0.0027%
28/09/26 Free

Chief Financial Officer

269,423 1.0136%
Change 5-day change 1-year change 3-year change Capi.($)
-5.20%+2.89%+15.98% - 408M
+1.56%+2.41%-14.09%+12.32% 184B
-6.38%-4.98%-18.07%+8.01% 112B
-0.59%+1.18%+6.44%+36.82% 118B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -1.15%+0.34%-5.21%+26.01% 75.97B
Weighted average by Cap. -0.49%+0.23%-10.13%+23.73%

Financials

2026 *2027 *
Net sales 76.71M 68.7M 63.2M 57.26M 107M 7.28B 109M 754M 303M 3.83B 288M 282M 12.08B 108M 96.82M 89.06M 80.69M 151M 10.26B 154M 1.06B 426M 5.4B 406M 397M 17.03B
Net income -40.36M -36.15M -33.25M -30.13M -56.32M -3.83B -57.37M -397M -159M -2.02B -151M -148M -6.36B -40.07M -35.88M -33.01M -29.91M -55.91M -3.8B -56.95M -394M -158M -2B -150M -147M -6.31B
Net Debt - -
Projected Income Statement - Annual - Carlsmed, Inc.
Logo Carlsmed, Inc.
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Employees
127
Date Price Change Volume
30/10/26 US$14.95 -5.20% 73,279
29/10/26 US$15.77 +3.00% 58,621
28/10/26 US$15.31 -0.71% 148,179
27/10/26 US$15.42 +3.42% 99,623
26/10/26 US$14.91 +2.62% 123,738
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Carlsmed, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.95USD
Average target price
19.40USD
Spread / Average Target
+29.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Carlsmed, Inc.
  1. Stock Market
  2. Stocks
  3. CARL Stock